Antipruritic Placebo Effects by Conditioning H1-antihistamine. [PDF]
Meeuwis SH +7 more
europepmc +1 more source
Effective treatment of different H1-antihistamine-refractory chronic urticaria phenotypes with omalizumab. [PDF]
Uysal P, Erge D.
europepmc +1 more source
In silico Evaluation of H1-Antihistamine as Potential Inhibitors of SARS-CoV-2 RNA-dependent RNA Polymerase: Repurposing Study of COVID-19 Therapy. [PDF]
Hamdan M, Kulabaş N, Küçükgüzel İ.
europepmc +1 more source
The Efficacy of a Two-Fold Increase of H1-Antihistamine in the Treatment of Chronic Urticaria - the Vietnamese Experience. [PDF]
Thi HT +21 more
europepmc +1 more source
Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study. [PDF]
Zhang WH +21 more
europepmc +1 more source
Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study. [PDF]
Fukunaga A +18 more
europepmc +1 more source
Surveillance of First-Generation H1-Antihistamine Use for Older Patients with Dementia in Japan: A Retrospective Cohort Study. [PDF]
Maeda T, Babazono A, Nishi T.
europepmc +1 more source
Loratadine, an H1 Antihistamine, Inhibits Melanogenesis in Human Melanocytes. [PDF]
Moon HR +7 more
europepmc +1 more source
Comparative pharmacology of the H1 antihistamines.
Cuvillo Bernal, Alfonso del +7 more
openaire +2 more sources
Gynecomastia induced by H1-antihistamine (ebastine) in a patient with idiopathic anaphylaxis. [PDF]
Jung HS +8 more
europepmc +1 more source

